Press Releases – Medical Darpan

For advertising Queries please call 9899152321 or email sales@medicaldarpan.com

Blog

20 Jan, 2022

Fermenta has signed a Definitive Agreement with Aurigene, a stepdown subsidiary of Dr Reddy’s Laboratories Limited

Fermenta Biotech Limited (FBL) today announced that it has signed a Definitive Agreement with Aurigene Pharmaceutical Services Limited (APSL), a stepd...

10 Jan, 2022

Alembic Pharmaceuticals receives USFDA Tentative Approval for Dronedarone Tablets

Alembic Pharmaceuticals Limited (Alembic) today announced that it has received tentative approval from the US Food & Drug Administration (USFDA) f...

8 Jan, 2022

AMGEN TO PRESENT AT THE 40TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

THOUSAND OAKS, Calif., Jan. 6, 2022 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will virtually present at the 40th Annual J.P. Morgan Healthcare Conference�...

7 Jan, 2022

NATCO Pharma Limited has been awarded Corporate Governance Award

NATCO Pharma Limited (the Company) pleased to inform that the Company has been awarded Corporate Governance Award for the year 2021 at the virtual eve...

7 Jan, 2022

Lupin launches Molnupiravir under the brand name Molnulup for the treatment of COVID-19 in adults in India

Mumbai, India, January 07, 2022: Global pharma major Lupin Limited (Lupin) announced the launch of Molnupiravir in India under the brand name Molnulu...

6 Jan, 2022

Amgen and Generate Biomedicines Announce Multi-Target, Multi-Modality Research Collaboration Agreement

THOUSAND OAKS, Calif. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan. 6, 2022-- Amgen (NASDAQ: AMGN) and Generate Biomedicines today announced a res...

5 Jan, 2022

Biohaven and Pfizer Complete Collaboration Transaction for Commercialization of Rimegepant and Zavegepant Outside United States

NEW HAVEN, Conn., and NEW YORK, January 5, 2022 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) and Pfizer Inc. (NYSE: PFE),...

1 Jan, 2022

NATCO completes acquisition of Dash Pharmaceuticals LLC01 January 2022

NATCO Pharma Inc. USA, a wholly owned subsidiary of NATCO Pharma Limited (NSE: NATCOPHARM; BSE: 524816) (“NATCO”), has completed the acquisition o...

28 Dec, 2021

Torrent Pharma to launch Molnupiravir under the brand name Molnutor® in India

Torrent Pharma has today announced that it is introducing MSD (a trade name of Merck & Co., Inc, Kenilworth, NJ, USA) and Ridgeback’s molnupirav...

28 Dec, 2021

Sun Pharma receives DCGI approval for Molxvir® (Molnupiravir) in India

Mumbai, December 28, 2021: Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun Pharma” a...

23 Dec, 2021

FedEx Marks Anniversary of First COVID-19 Vaccine Deliveries

INDIA, December 15, 2021 – One year ago, FedEx Express, a subsidiary of FedEx Corp. (NYSE: FDX) and one of the world’s largest express transporta...